News

Innovation must be matched with accessibility, affordability, and regulatory excellence in this digital age. At the heart of this transformation is Shaileshbhai Kaklotar, a trailblazer in ...
Google's Veo 3 image generator has taken the internet by storm, producing ultra-realistic AI videos from scratch. Here are ...
Emerson’s purpose-built industrial AI solutions are meant to enhance accessibility and reliability, enabling manufacturers to ...
RS Investments, an investment management company, released its “RS Large Cap Value Strategy” first quarter 2025 investor ...
This development, detailed in a recently published safety report, have led Anthropic to classify Claude Opus 4 as an ‘ASL-3’ ...
The EU’s proposal outlines mutual investment and procurement plans in artificial intelligence, digital connectivity, and ...
In related news, Singapore-based pharmaceutical company Mirxes, which specializes in cancer treatment, also had a strong debut in Hong Kong on the same day. The company’s shares rose by 28% in morning ...
Dystrophic epidermolysis bullosa (DEB) is one of the main subtypes of epidermolysis bullosa, a group of genetic skin disorders characterized by varying degrees of fragility in the skin and mucous ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced seven upcoming poster presentations at the 2025 American Society of ...
Morgans senior analyst Scott Power notes there's been a wave of capital raisings in the ASX healthcare sector as firms ...
Pivoting away from US exposure could help investors to hedge against the possible negative effects of Trump's tariffs.
Addressing drug shortages requires the industry to embrace innovative advanced manufacturing processes underpinned by ...